8 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Withdrawn 8 |
Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis Bimekizumab - Psoriasis Vulgaris, Active Psoriatic Arthritis | Phase 4 | Withdrawn | Innovaderm Research Inc. | 2023-01-01 | 2023-03-15 | |
| SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE Rosuvastatin - Psoriasis, Psoriatic Arthritis | Phase 4 | Withdrawn | Brigham and Women's Hospital | 2021-04-01 | 2021-07-23 | |
| An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound Secukinumab 300 mg, Placebo - Psoriasis | Phase 4 | Withdrawn | Novartis Pharmaceuticals | 2020-11-02 | 2023-03-31 | |
| Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast Apremilast - Psoriatic Arthritis | Phase 4 | Withdrawn | Medical University of Graz | 2020-07-01 | 2021-05-13 | |
| Treatment With Apremilast in Patients With Psoriatic Arthritis Treatment with Apremilast - Psoriatic Arthritis | Phase 4 | Withdrawn | University of South Florida | 2016-04-01 | 2016-10-21 | |
| Proton Pump Inhibitors Use in Patients With Psoriasis esomeprazole, desonide - Psoriasis | Phase 4 | Withdrawn | EMS | 2016-01-01 | 2022-08-05 | |
| Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis Steroid active treatment - Psoriasis | Phase 4 | Withdrawn | University of Zurich | 2011-08-01 | 2018-07-19 | |
| Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis Acitretin (also called U0279), Placebo, Etanercept - Plaque Psoriasis | Phase 4 | Withdrawn | Stiefel, a GSK Company | 2009-10-01 | 2015-04-21 |
Skin Diseases (8) · Skin Diseases, Papulosquamous (8) · Skin and Connective Tissue Diseases (8) · Arthritis (4) · Bone Diseases (4) · Joint Diseases (4) · Musculoskeletal Diseases (4) · Spinal Diseases (4) · Spondylarthritis (4) · Spondylarthropathies (4) · Spondylitis (4)
apremilast (2) · Acitretin (1) · Adrenal Cortex Hormones (1) · Desonide (1) · Esomeprazole (1) · Etanercept (1) · Rosuvastatin Calcium (1) · Therapeutics (1) · Triamcinolone (1) · bimekizumab (1) · secukinumab (1)
Brigham and Women's Hospital (1) · EMS (1) · Innovaderm Research Inc. (1) · Medical University of Graz (1) · Novartis Pharmaceuticals (1) · Stiefel, a GSK Company (1) · University of South Florida (1) · University of Zurich (1)
United States (2) · Austria (1) · Switzerland (1)
Guenther Hofbauer, MD (1) · John D Carter, MD (1) · Marcelo Di Carli, MD (1) · Robert Bissonnette, MD (1) · Rusmir Husic, Dr. (1)